154 related articles for article (PubMed ID: 35578571)
1. Interleukin 6/gp130 axis promotes neural invasion in pancreatic cancer.
Suzuki H; Mitsunaga S; Ikeda M; Aoyama T; Yoshizawa K; Yamaguchi M; Suzuki M; Narita M; Kawasaki T; Ochiai A
Cancer Med; 2022 Dec; 11(24):5001-5012. PubMed ID: 35578571
[TBL] [Abstract][Full Text] [Related]
2. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
[TBL] [Abstract][Full Text] [Related]
3. Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144.
Pozios I; Hering NA; Guenzler E; Arndt M; Elezkurtaj S; Knösel T; Bruns CJ; Margonis GA; Beyer K; Seeliger H
J Cancer Res Clin Oncol; 2023 Jan; 149(1):271-280. PubMed ID: 36495330
[TBL] [Abstract][Full Text] [Related]
4. Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL-6 trans-signalling.
Huo Y; Yang J; Zheng J; Xu D; Yang M; Tao L; Yao H; Fu X; Yang J; Liu D; Hua R; Zhang J; Sun Y; Hu L; Liu W
Cell Prolif; 2022 May; 55(5):e13237. PubMed ID: 35487760
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
7. MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma.
Zhu W; Wang Y; Zhang D; Yu X; Leng X
Biochem Biophys Res Commun; 2018 Mar; 497(4):963-970. PubMed ID: 29408481
[TBL] [Abstract][Full Text] [Related]
8. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
9. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
10. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
[No Abstract] [Full Text] [Related]
11. LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker.
Bressy C; Lac S; Nigri J; Leca J; Roques J; Lavaut MN; Secq V; Guillaumond F; Bui TT; Pietrasz D; Granjeaud S; Bachet JB; Ouaissi M; Iovanna J; Vasseur S; Tomasini R
Cancer Res; 2018 Feb; 78(4):909-921. PubMed ID: 29269518
[TBL] [Abstract][Full Text] [Related]
12. Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells.
Chen X; Tian J; Su GH; Lin J
Curr Cancer Drug Targets; 2019; 19(5):417-427. PubMed ID: 29714141
[TBL] [Abstract][Full Text] [Related]
13. KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages.
Li MX; Wang HY; Yuan CH; Ma ZL; Jiang B; Li L; Zhang L; Xiu DR
Clin Sci (Lond); 2021 Feb; 135(4):629-649. PubMed ID: 33538300
[TBL] [Abstract][Full Text] [Related]
14. Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.
Ishiguro S; Yoshimura K; Tsunedomi R; Oka M; Takao S; Inui M; Kawabata A; Wall T; Magafa V; Cordopatis P; Tzakos AG; Tamura M
Cancer Biol Ther; 2015; 16(2):307-16. PubMed ID: 25756513
[TBL] [Abstract][Full Text] [Related]
15. GOLPH2, a gene downstream of ras signaling, promotes the progression of pancreatic ductal adenocarcinoma.
Duan J; Li X; Huang S; Zeng Y; He Y; Liu H; Lin D; Lu D; Zheng M
Mol Med Rep; 2018 Mar; 17(3):4187-4194. PubMed ID: 29344673
[TBL] [Abstract][Full Text] [Related]
16. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation.
Zhou M; Pan S; Qin T; Zhao C; Yin T; Gao Y; Liu Y; Zhang Z; Shi Y; Bai Y; Gong J; Guo X; Wang M; Qin R
J Exp Clin Cancer Res; 2022 Sep; 41(1):288. PubMed ID: 36171592
[TBL] [Abstract][Full Text] [Related]
18. CD74 promotes perineural invasion of cancer cells and mediates neuroplasticity via the AKT/EGR-1/GDNF axis in pancreatic ductal adenocarcinoma.
Zhang JF; Tao LY; Yang MW; Xu DP; Jiang SH; Fu XL; Liu DJ; Huo YM; Liu W; Yang JY; Hua R; Lu P; Sun YW
Cancer Lett; 2021 Jun; 508():47-58. PubMed ID: 33766751
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification?
Linder S; Holmberg M; Engstrand J; Ghorbani P; Sparrelid E
Surg Oncol; 2022 May; 41():101735. PubMed ID: 35287096
[TBL] [Abstract][Full Text] [Related]
20. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma.
Wen Z; Liao Q; Zhao J; Hu Y; You L; Lu Z; Jia C; Wei Y; Zhao Y
Ann Surg Oncol; 2014 Jan; 21(1):125-32. PubMed ID: 24132627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
